Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed CFO
Quarterly results
Appointed director
Acq. announced
Inv. presentation
Microbot Medical Inc. (MBOT) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/27/2023 8-K Quarterly results
08/15/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Microbot Medical Boosts Manufacturing and Commercialization Capabilities for its Robotic Surgical System"
08/14/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/10/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Microbot Medical Strengthens Its Position Among US Interventional Radiologists by Appointing Professor Francois H. Cornelis to Its Scientific Advisory Board"
07/25/2023 8-K Quarterly results
07/18/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
07/18/2023 EFFECT Form EFFECT - Notice of Effectiveness:
07/14/2023 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
07/11/2023 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
07/11/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Microbot Medical Expands its Physician Support with the Addition of Leading Italian Interventional Radiologist Irene Bargellini, M.D., to its Scientific Advisory Board"
06/29/2023 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Microbot Medical Successfully Completes an Extensive Pre-Clinical Study Performed in the US"
06/16/2023 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Microbot Medical Announces Multiple Peer Reviewed Abstracts Accepted by The Cardiovascular and Interventional Radiological Society of Europe"
06/06/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...
Docs: "SERIES C PREFERRED INVESTMENT OPTION Microbot Medical Inc. Preferred Investment Option Shares: ______ Issue Date: June ___, 2023 Initial Exercise Date: June ___, 2023 THIS SERIES C PREFERRED INVESTMENT OPTION certifies that, for value received, _____________ or its assigns is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above and on or prior to 5:00 p.m. on December ___, 2028 1 but not thereafter, to subscribe for and purchase from Microbot Medical Inc., a Delaware corporation , up to ______ shares of Common Stock. The purchase price of one share of Common Stock under this Preferred Investment Option shall be equal to the Exercise Price, as defined in Section 2. Section 1 . Definitio...",
"PLACEMENT AGENT PREFERRED INVESTMENT OPTION Microbot Medical Inc. Preferred Investment Option Shares: ______ Initial Exercise Date: June 6, 2023 THIS PLACEMENT AGENT PREFERRED INVESTMENT OPTION certifies that, for value received, _____________ or its assigns is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above and on or prior to 5:00 p.m. on June 2, 2028 but not thereafter, to subscribe for and purchase from Microbot Medical Inc., a Delaware corporation , up to ______ shares of Common Stock. The purchase price of one share of Common Stock under this Preferred Investment Option shall be equal to the Exercise Price, as defined in Section 2. This Preferred Investment Option is being is...",
"25 Recreation Park Drive, Unit 108",
"SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement is dated as of June 2, 2023, between Microbot Medical Inc., a Delaware corporation , and each purchaser identified on the signature pages hereto . WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities Act as to the Shares and the Pre-Funded Warrants and an exemption from the registration requirements of Section 5 of the Securities Act contained in Section 4 thereof and/or Regulation D thereunder as to the Preferred Investment Options, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agre...",
"Microbot Medical Announces $1.5 Million Registered Direct Offering Priced At-The- Market under Nasdaq Rules",
"Microbot Medical Announces Closing of $1.5 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules"
06/05/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
06/02/2023 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Microbot Medical Receives a Non-Dilutive Grant from The Israel Innovation Authority Supporting the Development of the Manufacturing Process for its Endovascular Surgical Robotic System"
05/31/2023 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "LIBERTY Robotic Surgical System Achieved Additional Milestone in its Path to First in Human and Regulatory Process"
05/25/2023 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
05/24/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Material Modifications to Rights of Secu...
Docs: "PRE-FUNDED COMMON STOCK PURCHASE WARRANT Microbot Medical Inc. Warrant Shares: Initial Exercise Date: May 24, 2023 THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT certifies that, for value received, or its assigns is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above until this Warrant is exercised in full but not thereafter, to subscribe for and purchase from Microbot Medical Inc., a Delaware corporation , up to shares of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2. Section 1 . Definitions . Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that...",
"PLACEMENT AGENT PREFERRED INVESTMENT OPTION Microbot Medical Inc. Preferred Investment Option Shares: ______ Initial Exercise Date: November 24, 2023 THIS PLACEMENT AGENT PREFERRED INVESTMENT OPTION certifies that, for value received, _____________ or its assigns is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above and on or prior to 5:00 p.m. on November 24, 2026 but not thereafter, to subscribe for and purchase from Microbot Medical Inc., a Delaware corporation , up to ______ shares of Common Stock. The purchase price of one share of Common Stock under this Preferred Investment Option shall be equal to the Exercise Price, as defined in Section 2. This Preferred Investment Option i...",
"SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement is dated as of May 23, 2023, between Microbot Medical Inc., a Delaware corporation , and each purchaser identified on the signature pages hereto . WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities Act , the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement. NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser agr...",
"Holder of Preferred Investment Options to Purchase Common Stock",
"Microbot Medical Announces $2.66 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules",
"Microbot Medical Announces Closing of $2.66 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules"
05/24/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
05/23/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...
Docs: "PLACEMENT AGENT PREFERRED INVESTMENT OPTION Microbot Medical Inc. Preferred Investment Option Shares: ______ Initial Exercise Date: November 23, 2023 THIS PLACEMENT AGENT PREFERRED INVESTMENT OPTION certifies that, for value received, _____________ or its assigns is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above and on or prior to 5:00 p.m. on November 23, 2026 but not thereafter, to subscribe for and purchase from Microbot Medical Inc., a Delaware corporation , up to ______ shares of Common Stock. The purchase price of one share of Common Stock under this Preferred Investment Option shall be equal to the Exercise Price, as defined in Section 2. This Preferred Investment Option i...",
"25 Recreation Park Drive, Unit 108",
"SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement is dated as of May 22, 2023, between Microbot Medical Inc., a Delaware corporation , and each purchaser identified on the signature pages hereto . WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities Act , the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement. NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser agr...",
"Microbot Medical Announces $1.4 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules",
"Microbot Medical Announces Closing of $1.4 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules"
05/23/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
05/18/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Microbot Medical to Enhance Focus on its Core Business and Prioritize Preparations for Regulatory and First in Human Clinical Cases"
05/17/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/16/2023 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
05/08/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Microbot Medical Initiates Preparations for First-In-Human Cases in Brazil for the LIBERTY Robotic System"
05/05/2023 8-K Quarterly results
05/03/2023 8-K Quarterly results
03/31/2023 10-K Annual Report for the period ended December 31, 2022
03/23/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Gerry O’ Sullivan, the Latest Member to Join Microbot Medical’ s Scientific Advisory Board, to Leverage Extensive Interventional Radiology Experience to Progress the LIBERTY Robotic System Through Regulatory, Clinical and Commercialization Phases"
03/16/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Microbot Medical Launches Presence in the United Kingdom as Highly Accomplished Consultant Interventional Radiologist Professor Mark W. Little Joins its Scientific Advisory Board as Efforts to Commercialize the LIBERTY® Robotic System Continue to Accelerate"
03/13/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Microbot Medical Increases Presence in the EU with the Addition of Greece-based Key Opinion Leader Stavros Spiliopoulos, MD, PhD, EBIR-ES, FCIRSE, to its Scientific Advisory Board"
03/09/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Microbot Medical’ s Chief Medical Officer Dr. Eyal Morag to Highlight Performance, Safety and Usability Benefits of the LIBERTY ® Robotic System During Podium Presentation at Prestigious Robotics Conference"
03/02/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Microbot Medical Leverages Recently Awarded Non-Dilutive Grant from the Israeli Government to Promote Marketing Activities Toward Commercialization of the LIBERTY® Robotic System"
02/28/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Microbot Medical Meeting with Key Opinion Leaders, Hospital Administrators, and Potential Strategic and Commercial Partners at the Society of Interventional Radiologist Annual Meeting"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy